What Will Matter Most for Successful Healthcare M&A in This Cycle?

In a market defined by higher rates, tighter capital, and increased regulatory scrutiny, healthcare M&A is no longer just about finding the right asset — it’s about managing complexity after the deal closes

Where Healthcare Is Growing Fast... and Falling Behind

Wellness economics are booming — but TeleHealth still has a trust problem

The Healthcare Transformation of the Wellness Economy and the Fitness Technology Ecosystem

Market Muscle, Capital Shifts, and a $285M Signal to Europe

HealthTech capital is concentrating: NA leads, payers feel the pressure, and digital MSK consolidation accelerates.

Telehealth Is Booming. Here’s What Comes Next.

Telehealth’s trillion-dollar trajectory, 2026 tech budget priorities, and the engagement gap reshaping virtual care.

Telehealth’s Next Phase: Scale, Integration, and Value Creation

A data-driven analysis of market growth, regional dynamics, and end-use economics shaping virtual care through 2035

GLP-1s Go Prime Time, Sub-$50M M&A Rebounds, and 67% Back Specialty Care

Pharma pushes weight-loss drugs to the mass market and small deals clear 4 in 60 days, while India’s patient satisfaction drops to 46%.

Where Healthcare M&A Is Most Likely to Hold Up in 2026

Healthcare dealmaking may be slower and more selective, but it’s far from stalled.

Who’s Winning in Healthcare Now: AI Megadeals, Staffing Giants & Telehealth Choices

Deal count surges in healthcare AI and compliance tightens on staffing, while reliability drives 66% of telehealth platform decisions.

AI Is Outgrowing the Mega-Deal

For years, healthcare AI funding followed a familiar arc: bigger rounds, fewer companies, and a steady march toward “mega-deals.” In 2025, that narrative is starting to bend.

AstraZeneca’s $15B Bet, €4bn Pharma Exit, and 36% Skip Care

AstraZeneca commits $15B to China and Permira eyes a €4bn sale of Neuraxpharm, while high costs force 36% of rural U.S. patients to forgo treatment.

$9.9M HIPAA Fines, 50% Integration Pain, 78% Betting On AI

78% of leaders turn to AI for efficiency and $9.9M in HIPAA fines signals tougher enforcement, while integration complexity stalls virtual care for 50%.